China Health Review

CHPAMS Policy on Inspiration Award

Zhuo (Adam) Chen — Thu, 15 Sep 2016 00:00:00 -0400

CHPAMS Policy on Inspiration Award

Date First Published: 05/25/2016

Date Revised: 08/07/2016; 09/05/2016

A. Purpose

This award is to recognize CHPAMS members’ extraordinary determination to challenge the “status quo”, overcome significant barriers and achieve accomplishments in scientific research, community service, or innovative activities that are beyond-expectation. The accomplishments should be in line with the mission of the China Health Policy and Management Society (CHPAMS). The preferred candidates are CHPAMS members who are in their early career stage. The awardees’ actions or achievements should have challenged others’ existing view on a particular subject in health-related fields to better serve CHPAMS’s mission, and therefore, inspire others to act in the same manner.

B. Selection Criteria

A nominee must be a registered CHPAMS member and demonstrates the qualifications satisfying at least one of the following criteria:

The nominee challenges and addresses a scientific question in health or health-related fields that may significantly change the established view, form a breakthrough, or substantially benefit large populations;

The nominee demonstrates persistence, dedication, or leadership in serving the health needs of a particular vulnerable group that might be otherwise ignored or underserved by the existing health system. The community service must be exemplary and exceed the normal expectation.

The nominee creates innovative tools, methods, or other intellectual products that may not fit into a formal research field but can motivate others and benefit the health of a specific or general population.

If the achievement is completed by a group of individuals, only the leader or the key person(s) who played a significant beyond-duty role is(are) qualified as long as they meet the requirements as defined in this policy and agreed upon by the group members unanimously.

C. Application Process

CHPAMS will form an award committee of five members that consist of President of CHPAMS or his/her designee, CHPAMS advisors and other distinguished members or guests and one member will be elected as the Chair of the Committee.

The nominating member should email the following documents to the Chair of the Award Committee by October 1 of the award year:

A cover letter of no more than 1,000 words in English to describe the qualification of the nominee.

Additional documents or materials (optional but no more than three documents or a total of 10 pages) that describes the inspiration of the nominee’s actions and/or demonstrates the outcome, such as media report, award certificate, witness testimony, or any other evidence that supports the nominee’s application.

D. Selection Process

The Award Committee will screen and review all nomination materials and may conduct phone or in-person interviews with the finalists. The Award Committee will have a formal meeting to discuss the nominees and vote on the final winner. CHPAMS will announce the winner on February 1 of the following year. The winner will receive $500 at minimum and an award plaque. The award amount may be increased by the CHPAMS Board of Directors with additional resources available.

The Award Committee will uphold a high standard in the selection process. If no nominee meets the expectation from the award committee, the award funding will be rolled over to next year. No more than two winners can be awarded in any given year.

Impacts of China’s One-child Policy on Public Health in China: An Overview

Zheng Li, Ziwei Song — Thu, 01 Sep 2016 00:00:00 -0400

Abstract

In 2015, China lifted its one-child policy and replaced it with a universal two-child policy that became effective on January 1, 2016. The one-child policy, introduced in 1979 to strictly reduce population growth in the country, had profound impacts not only on population growth control, but also on public health and many other aspects affecting population health. In this article, we review its positive impacts on public health in China, such as greatly improved health status in the country, most likely due to the combination of the one-child policy and the economic reform that started approximately the same time. We also discussed several undesirable outcomes, such as skewed sex ratio and aging population. Finally, we proposed potential strategies to compliment the newly implemented two-child policy.

摘要: 2015年底，中国宣布取消独生子女政策，并于2016年一月一日开始实施二孩政策。自从1979，独生子女政策在过去30多年减缓了中国的人口增长，同时也在公共卫生和人口健康有深远的影响。这篇概述回顾独生子女政策在公共卫生方面的积极影响，也讨论了一些政策的负面影响，比如偏倚的男女比例和加速老龄化。最后，本篇概述提出一些让二孩政策更好实施的策略。

关键词：中国，独生子女政策，公共卫生，妇幼健康，性别比，老龄化社会

Interview with Ms. Pan, Beijing United Family Hospital and Clinics

Nan Jiang — Thu, 01 Sep 2016 00:00:00 -0400

Ms. Zhongying Pan is the Vice President of United Family Hospital and Clinics Group, and the President of Beijing United Family Hospital and Clinics. She joined Beijing United Family Hospital and Clinics in 1996. In her fourteen years of career, she served as a project manager, administrative manager, interim general manager of Shanghai United Family Hospital, Acting President, and Vice President of strategic development system. As a practitioner, she is an expert in foreign-invested hospital management in China. Ms. Pan has in-depth experience in government relations, hospital operations, strategic business planning, local market expansion, and multicultural human resources management. In her career at Beijing United Family Hospital and Clinics, she was in charge of the approval of foreign-invested hospital opening, budgeting, supervision, project budget preparation, quality control, drug and medical equipment import, non-medical personnel management, and all aspects of recruitment and training. Ms. Pan has comprehensive understanding of China's health care system, policies and regulations. She has great knowledge of foreign hospital investment in China and deep insight into the current situation and development of China's healthcare market. Ms. Pan continues to pursue her PhD degree in Hospital Management from University of Alabama at Birmingham. She received her MBA in Healthcare Management at University of Colorado, MBA at Peking University, and BA in English Literature at the Xiangtan University.

简介：盘仲莹女士现担任和睦家医疗集团副总裁、北京和睦家医院院长职务。她于1996年正式加入和睦家医疗，在其十四年的职业生涯中，她历任项目经理，行政经理，总经理助理，上海和睦家医院代理院长，战略系统发展副总裁，具备丰富的外资医院管理经验。盘仲莹女士在政府关系到医院运营管理，在战略业务规划到地方市场拓展和在企业多元文化的塑造到人力资源的管理，拥有深入的实践经验。在和睦家的职业生涯中，她曾亲自负责外资医院的批准、筹建及项目的预算、监理，项目预算控制到医疗设备、药品的进口以及非医疗人才的招聘到管理培训等各方面。盘仲莹女士全面了解中国的医疗体制、各项政策法规；深谙外资医院在华发展之道；洞悉中国医疗健康市场的现状与发展。她仍在不断学习中，在繁忙的工作之余，盘仲莹女士还在继续攻读美国阿拉巴马大学伯明翰分校医院管理博士学位。她于湘潭大学获得英语文学系学士学位，后取得北京大学工商管理硕士学位以及美国科罗拉多大学卫生保健专业工商管理硕士学位。